Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01730586 · BASELINE

Baseline characteristics

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas · Source last updated 2020-01-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      34
    units
    Participants
groups
  1. description
    Abraxane 220 mg/m\^2 intravenously on Day 1 of 21 day cycle.
    id
    BG000
    title
    Abraxane
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          34
          upper Limit
          77
          value
          59
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          20
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        title
        Small Bowel Adenocarcinoma (SBA)
      2. measurements
        1. group Id
          BG000
          value
          21
        title
        CIMP-high Colorectal Cancer (CRC)
    description
    Histologically or cytologically confirmed colorectal adenocarcinoma (CpG island methylator phenotype (CIMP-high)) or small bowel adenocarcinoma
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Colorectal Cancer Diagnosis
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      34
    units
    Participants
groups
  1. description
    Abraxane 220 mg/m\^2 intravenously on Day 1 of 21 day cycle.
    id
    BG000
    title
    Abraxane
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          34
          upper Limit
          77
          value
          59
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          20
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
        title
        Small Bowel Adenocarcinoma (SBA)
      2. measurements
        1. group Id
          BG000
          value
          21
        title
        CIMP-high Colorectal Cancer (CRC)
    description
    Histologically or cytologically confirmed colorectal adenocarcinoma (CpG island methylator phenotype (CIMP-high)) or small bowel adenocarcinoma
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Colorectal Cancer Diagnosis
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice